Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes

May 2011
Diabetes Care;May2011 Supplement 2, Vol. 34, pS244
Academic Journal
The article discusses the rationale for the use of a bile acid sequestrant (BAS) to treat type 2 diabetes. It describes the clinical effects of the BAS, known as colesevelam hydrochloride, that has been approved for both glycemic and lipid control in the U.S. As new agents are approved in the market, the treatment strategies for type 2 diabetes also changed. Example of oral anti-diabetes agents include biguanides, BAS, and dipeptidyl peptidase-4 inhibitors. Aside from BAS, other lipid-lowering agents used to treat hypercholesterolemia are listed.


Related Articles

  • Concomitant Reduction in Low-Density Lipoprotein Cholesterol and Glycated Hemoglobin With Colesevelam Hydrochloride in Patients With Type 2 Diabetes: A Pooled Analysis. Ishwarlal Jialal; Stacey L. Abby; Soamnauth Misir; Sukumar Nagendran // Metabolic Syndrome & Related Disorders;Jun2009, Vol. 7 Issue 3, p255 

    Colesevelam hydrochloride (COL), a bile acid sequestrant indicated as an adjunct to diet and exercise for reducing low-density lipoprotein cholesterol (LDL-C) in patients with primary hypercholesterolemia, was shown in a pilot study to reduce both glycated hemoglobin (HbA1c) and LDL-C in...

  • Medications for Type 2 Diabetes. Tanenberg, Robert J. // Diabetes Health;Feb2005, Vol. 14 Issue 2, p25 

    Presents information on the medications for type 2 diabetes. Emergence of meglitinides and phenylalanine derivatives in the U.S. market; Benefits of such drugs; Features offered by the Metformin biguanide for patients.

  • Insulin Sensitizers. Zangeneh, Farhad; Judva, Yogish C.; Basu, Ananda // Mayo Clinic Proceedings;Apr2003, Vol. 78 Issue 4, p471 

    Studies the efficacy of insulin sensitizer drugs in the treatment of type-2 diabetes mellitus. Types of insulin sensitizer drugs; Role in glycemic control; Other beneficial effects of insulin sensitizer drugs; Implication for other related metabolic conditions such as polycystic ovary syndrome.

  • Oral Agents in the Management of Type 2 Diabetes Mellitus.  // American Family Physician;5/1/2001, Vol. 63 Issue 9, p1747 

    Examines the effectiveness of several oral agents in the treatment of type 2 diabetes mellitus. How sulfonylureas work; nset of action of meglitinides; Side effect profile of biguanides.

  • FXR is a molecular target for the effects of vertical sleeve gastrectomy. Ryan, Karen K.; Tremaroli, Valentina; Clemmensen, Christoffer; Kovatcheva-Datchary, Petia; Myronovych, Andriy; Karns, Rebekah; Wilson-Pérez, Hilary E.; Sandoval, Darleen A.; Kohli, Rohit; Bäckhed, Fredrik; Seeley, Randy J. // Nature;5/8/2014, Vol. 509 Issue 7499, p183 

    Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms...

  • Metformin: A New Treatment Option for Non-Insulin-Dependent Diabetes Mellitus. Goo, Alvin K. Y.; Carson, Deborah Stier; Bjelajac, Aleksandra // Journal of Family Practice;Jun1996, Vol. 42 Issue 6, p612 

    Metformin is a biguanide that can used alone or in combination with sulfonylureas or insulin in the treatment of non-insulin-dependent diabetes mellitus (NIDDM). Since biguanides do not increase pancreatic insulin secretion, they are referred to as antihyperglycemic agents, as opposed to...

  • Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. BRIDGES, Hannah R.; JONES, Andrew J. Y.; POLLAK, Michael N.; HIRST, Judy // Biochemical Journal;9/15/2014, Vol. 462 Issue 3, p475 

    The biguanide metformin is widely prescribed for Type II diabetes and has anti-neoplastic activity in laboratory models. Despite evidence that inhibition of mitochondrial respiratory complex I by metformin is the primary cause of its cell-lineage-specific actions and therapeutic effects, the...

  • biguanide (by-GWAH-nide).  // Diabetes Dictionary (NIDDK);10/1/2005, p4 

    A definition of the medical term "biguanide" is presented. It refers to a class of oral medicine used to treat type 2 diabetes that lowers blood glucose by reducing the amount of glucose produced by the liver and helps the body respond better to insulin. The definition is from the "Diabetes...

  • biguanide (Major drug group).  // Royal Society of Medicine: Medicines;2002, p115 

    The article presents information on biguanide drugs, a chemical class of orally administered hypoglycemic drugs. These drugs are used to treat Type II diabetes. How they work is complex, but it is thought to involve an effect on glucose uptake by skeletal muscle, glucose absorption and production.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics